HP-211 (Axulin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HP-211 (Axulin), covering 2020-04-20 to 2020-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Acute Effect of HP-211 (Axulin) on Blood Glucose and Serum Insulin Responses in Healthy Lean and Overweight Humans [Phase 1]